University of Maryland, Baltimore: Lung Neoplasms trials

The registry lists 13 Lung Neoplasms studies with University of Maryland, Baltimore as lead sponsor. 4 are open to participants now and 2 have results posted.

Phase 1 5Phase 2 4No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• GCC 2545- Improving Post-Radiotherapy Respiratory Function Through Sparing Serial and Parallel Components in the LungNot yet recruitingNCT07679607Phase 2
• GCC 2546- Motion ManagementRecruitingNCT07398209Not applicable
• Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung CancerRecruitingNCT07008664
• Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung CancerRecruitingNCT05450965Phase 2
• Dynamic Magnetic Resonance Imaging (MRI) for Lung Tumor Motion and Lung Function (GCC 0943)CompletedNCT01016938Results posted
• 0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung CancerCompletedNCT00771953Phase 2Results posted
• Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLCSuspendedNCT05403723Phase 1
• Lung SBRT Motion Management (GCC 1619)TerminatedNCT02695680
• Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine CarcinomasWithdrawnNCT02030184Phase 1/2
• Trial Of Cisplatin And KML-001 in Platinum Responsive MalignanciesTerminatedNCT01110226Phase 1
• Stereotactic Body Radiation Therapy (SBRT) as a Boost After Definitive Concurrent Chemoradiation (ChemoRT) for Non-Small Cell Lung Cancer (NSCLC) GCC 0516WithdrawnNCT00818714Phase 1
• Investigating the Improvement in 4D CT Images Using AV BiofeedbackCompletedNCT00780611
• LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian CancerCompletedNCT00005858Phase 1